Elevance Health(ELV)
$429.90+0.42 (+0.10%)
ELV
Elevance Health stock kpis
$429.90
At close:+0.42 (+0.10%)
Want to see ELV full AI Analyst Report?
Revenue by Segment
Breaks down earnings from different business units, highlighting which segments drive growth and where strategic focus may be needed.
Premiums are the primary growth driver, accelerating since 2024 and underpinning the stronger cash flow and the raise in EPS guidance; growth looks driven by pricing/membership mix and improving Medicare Advantage performance. Product revenue has grown materially, aligning with Carelon/CarelonRx and integrated medical+pharmacy momentum and offering durable upside. Still, Medicaid margin pressure, planned market exits and near‑term investments mean revenue gains may lag margin recovery, and the Q2 $0.80/‑share benefit was one‑time, not a recurring earnings cushion.
ELV Revenue by Segment
| Date | Premiums | Product Revenue | Service Fees and Other |
|---|---|---|---|
| Sep 30, 2026 | $41.70B | $6.45B | $2.28B |
| Jun 30, 2026 | $41.28B | $6.26B | $2.28B |
| Mar 31, 2026 | $41.02B | $6.22B | $2.25B |
| Dec 31, 2025 | $40.69B | $6.46B | $2.16B |
| Sep 30, 2025 | $41.79B | $6.16B | $2.14B |
| Jun 30, 2025 | $41.27B | $6.04B | $2.11B |
| Mar 31, 2025 | $40.89B | $5.81B | $2.07B |
| Dec 31, 2024 | $36.24B | $6.71B | $2.03B |
| Sep 30, 2024 | $36.81B | $5.89B | $2.02B |
| Jun 30, 2024 | $35.42B | $5.53B | $2.28B |
| Mar 31, 2024 | $35.70B | $4.50B | $2.08B |
| Dec 31, 2023 | $35.14B | $5.39B | $1.92B |
| Sep 30, 2023 | $35.26B | $5.18B | $2.04B |
| Jun 30, 2023 | $36.59B | $4.86B | $1.93B |
| Mar 31, 2023 | $35.87B | $4.02B | $2.01B |
| Dec 31, 2022 | $33.65B | $4.14B | $1.88B |
| Sep 30, 2022 | $33.72B | $3.97B | $1.93B |
| Jun 30, 2022 | $33.08B | $3.57B | $1.84B |
| Mar 31, 2022 | $32.78B | $3.30B | $1.80B |
| Dec 31, 2021 | $30.77B | $3.52B | $1.72B |
| Sep 30, 2021 | $30.39B | $3.35B | $1.80B |
| Jun 30, 2021 | $28.53B | $3.04B | $1.70B |
| Mar 31, 2021 | $27.68B | $2.74B | $1.69B |
| Dec 31, 2020 | $27.11B | $2.90B | $1.53B |
| Sep 30, 2020 | $26.39B | $2.60B | $1.66B |
| Jun 30, 2020 | $25.09B | $2.54B | $1.54B |
| Mar 31, 2020 | $25.52B | $2.34B | $1.59B |
| Dec 31, 2019 | $24.04B | $1.50B | $1.60B |
| Sep 30, 2019 | $23.79B | $1.12B | $1.53B |
| Jun 30, 2019 | $23.50B | $144.00M | $1.53B |
| Mar 31, 2019 | $22.84B | $0.00 | $1.54B |
